So-Young International Inc (SY) Stock Analysis

AI analysis of So-Young International Inc (SY)

Hold

So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.

Valuation Metrics

The current forward P/E ratio for So-Young International Inc (SY) is 16.29, compared to its 5-year average forward P/E of -8.30.

Forward P/E

Fair

5Y Average P/E

-8.30

Current P/E

16.29

Overvalued

74.09

Undervalued

-90.69

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-21.74

Current EV/EBITDA

-0.23

Overvalued

46.57

Undervalued

-90.06

Forward P/S

Undervalued

5Y Average P/S

0.63

Current P/S

0.07

Overvalued

1.07

Undervalued

0.19

Alphio AI Price Scenarios for SY

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SY

$0.73

Scenario price

B

Base

Base · 50%SY

$0.70

Scenario price

B

Bear

Bear · 25%SY

$0.56

Scenario price

Whales holding SY

O

Oasis Management Company Ltd.

+ HoldingSY

-12.75%

3M Return

SY FAQ — answered by Alphio AI

So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website. It operates in the Consumer Cyclicals sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).

So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.